Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms

Comparisons between everolimus and sunitinib regarding their efficacy and safety in neuroendocrine neoplasms (NENs) are scarce. We retrospectively analysed the clinicopathological characteristics and outcomes in 92 patients with well-differentiated (WD) NEN of different origin (57 pancreatic NENs (P...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocr Connect
Main Authors: Daskalakis, Kosmas, Tsoli, Marina, Angelousi, Anna, Kassi, Evanthia, Alexandraki, Krystallenia I, Kolomodi, Denise, Kaltsas, Gregory, Koumarianou, Anna
Format: Artigo
Sprog:Inglês
Udgivet: Bioscientifica Ltd 2019
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528409/
https://ncbi.nlm.nih.gov/pubmed/31026812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0134
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker